Fabrazyme® (agalsidase beta)
| Full Name | Fabrazyme® (agalsidase beta) |
| Drug | Fabrazyme |
| Manufacturer | Sanofi Genzyme |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | The treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease |
| Disease | Fabry disease |
| Therapeutic Area | Neurology, Nephrology, Genetics |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-240-9572 |
| Fax Number | 877-220-7581 |
| Product Website | hcp.fabrazyme.com |